Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.0179640718562873 -0.0239520958083831 -0.0508982035928142
Stock impact report

Alder Bio launches $200M convertible debt offering [Seeking Alpha]

ALDER BIOPHARMACEUTICALS INC (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806
Company Research Source: Seeking Alpha
Alder Bio launches $200M convertible debt offeringAlder BioPharmaceuticals (NASDAQ:ALDR)commences a $200M offering of convertible senior notes due 2025. Underwriters will have a 30-day option to buy up to an additional $30M of the notes. Net proceeds will fund the development and commercialization of eptinezumab.Price and terms have yet to be announced.Click to subscribe to real-time analytics on ALDRNow read:Alder Bio (ALDR) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow » Show less Read more
Impact Snapshot
Event Time:
ALDR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALDR alerts
Opt-in for
ALDR alerts

from News Quantified
Opt-in for
ALDR alerts

from News Quantified